Augment Biologics

Better Medicine Through Better Surface Engineering

San Francisco, United States · Founded 2021 · $7.7M raised

Founded
2021
Business Model
B2B
Total Funding
$7.7M
Last Round
$150K SeedAug 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Augment Biologics is a platform-enabled biopharmaceutical company using foundational discoveries in glycobiology to transform biologic drug development. The company developed GlycoTemplating, an AI-guided glycoprotein-drug design platform that writes glycans directly into the primary protein sequence with site-specific accuracy. Unlike traditional glycoengineering methods, GlycoTemplating is expression-platform-agnostic and improves drug efficacy, safety, durability, and manufacturability. The platform is built on discoveries in glycan biosynthesis from the Lewis Lab at UCSD and the University of Georgia. Near-term applications focus on antibody, protein, and peptide engineering; long-term applications extend to RNA therapeutics, delivery vehicles, and vaccine development. In 2025, the company joined the Recode Ventures Edge cohort and was selected for MassBio Drive.

Summary

Augment Biologics is an Artificial Intelligence company based in San Francisco, United States, founded in 2021. It has raised $7.7M in total across 2 rounds, most recently a $150K Seed round in Aug 2025. Investors include SOSV and IndieBio.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedAug 2025
$150K

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026
Waymo

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

Mountain View, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Venture RoundTotal funding$29.6BFeb 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Augment Biologics on Indexed.vc
<a href="https://indexed.vc/companies/augment-biologics"><img src="https://indexed.vc/api/badge/company/augment-biologics" alt="Augment Biologics on Indexed.vc" width="260" height="76" /></a>